BC Advantage Funds

Aquinox Pharmaceuticals Inc., based in Vancouver, Canada, is a clinical-stage pharmaceutical company focused on discovering and developing oral drug candidates for the treatment of inflammatory diseases and cancer. Founded in 2004, the company is engaged in the development and commercialization of small molecule therapeutics. Its notable offerings include AQX-MN100, a drug targeting both cancer and inflammatory conditions, alongside a program aimed at SH2-containing inositol 5'-phosphatase inhibition for blood cell recovery. As of July 2020, Aquinox Pharmaceuticals operates as a subsidiary of Taro Pharmaceuticals Inc.

Inimex Pharmaceuticals Inc. is a biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of innate defense regulators (IDRs). These innovative agents are designed to selectively modulate the body's innate immune responses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, mitigate tissue damage, and decrease the risk of bacterial infections. Inimex's IDRs are intended for the treatment of various infections and conditions related to tissue injury, including ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is focused on advancing its clinical-stage products to improve patient outcomes.

Mobidia Technology Inc., established in 2004 and headquartered in Richmond, Canada, specializes in providing global mobile app and network usage data solutions. The company offers datasets including app data, network data, device data, and plan data, along with methodology, delivery, and dashboard solutions. Mobidia's platforms enable businesses to track competitors, identify trends, optimize data plans, develop over-the-top strategies, and target advertising effectively using real-world usage data worldwide. Notably, Mobidia is also the provider of the popular My Data Manager application for iOS and Android users. As of May 6, 2015, Mobidia operates as a subsidiary of App Annie Limited.

Aquinox Pharmaceuticals Inc., based in Vancouver, Canada, is a clinical-stage pharmaceutical company focused on discovering and developing oral drug candidates for the treatment of inflammatory diseases and cancer. Founded in 2004, the company is engaged in the development and commercialization of small molecule therapeutics. Its notable offerings include AQX-MN100, a drug targeting both cancer and inflammatory conditions, alongside a program aimed at SH2-containing inositol 5'-phosphatase inhibition for blood cell recovery. As of July 2020, Aquinox Pharmaceuticals operates as a subsidiary of Taro Pharmaceuticals Inc.

Contigo Systems Inc. is a Canadian company that specializes in developing and managing a location-based services platform designed for businesses to monitor their vehicles, assets, and personnel through the Internet. The company offers solutions such as RideAlong, a GPS tracking system that supports fleet, asset, and personnel management. Additionally, Contigo provides enterprise-grade lone worker alert solutions aimed at enhancing the safety of mobile workers who operate alone or in high-risk environments, ensuring compliance with relevant legislation. The company distributes its products through a network of strategic partners and value-added resellers, serving enterprise customers and major wireless carriers primarily in the United States and Canada. Founded in 2002 and originally known as Guardian Mobile Monitoring Systems, Contigo is headquartered in Vancouver, British Columbia, with an additional office in Santa Monica, California. As of early 2016, it operates as a subsidiary of Vecima Networks Inc.

Mobidia Technology Inc., established in 2004 and headquartered in Richmond, Canada, specializes in providing global mobile app and network usage data solutions. The company offers datasets including app data, network data, device data, and plan data, along with methodology, delivery, and dashboard solutions. Mobidia's platforms enable businesses to track competitors, identify trends, optimize data plans, develop over-the-top strategies, and target advertising effectively using real-world usage data worldwide. Notably, Mobidia is also the provider of the popular My Data Manager application for iOS and Android users. As of May 6, 2015, Mobidia operates as a subsidiary of App Annie Limited.

Mobidia Technology Inc., established in 2004 and headquartered in Richmond, Canada, specializes in providing global mobile app and network usage data solutions. The company offers datasets including app data, network data, device data, and plan data, along with methodology, delivery, and dashboard solutions. Mobidia's platforms enable businesses to track competitors, identify trends, optimize data plans, develop over-the-top strategies, and target advertising effectively using real-world usage data worldwide. Notably, Mobidia is also the provider of the popular My Data Manager application for iOS and Android users. As of May 6, 2015, Mobidia operates as a subsidiary of App Annie Limited.